Pages that link to "Q37005285"
Jump to navigation
Jump to search
The following pages link to Immunopathogenesis and role of T cells in psoriasis (Q37005285):
Displaying 50 items.
- Substantial alterations of the cutaneous bacterial biota in psoriatic lesions (Q21144280) (← links)
- Topical treatments for chronic plaque psoriasis (Q24198258) (← links)
- Topical treatments for chronic plaque psoriasis (Q24241239) (← links)
- The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings (Q24623195) (← links)
- Jakpot! New small molecules in autoimmune and inflammatory diseases (Q27001957) (← links)
- A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia (Q28587867) (← links)
- Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab (Q33573621) (← links)
- Anti-TNFα therapy in the management of psoriasis: experience of a state referral center (Q33752359) (← links)
- Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders (Q33844788) (← links)
- Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions (Q33889471) (← links)
- Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis (Q34025504) (← links)
- Pathogenic Mechanisms Shared between Psoriasis and Cardiovascular Disease (Q34107573) (← links)
- DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes (Q34145717) (← links)
- The pathophysiological role of dendritic cell subsets in psoriasis (Q34180103) (← links)
- Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease (Q34262223) (← links)
- Peptides and peptidomimetics as immunomodulators (Q34359984) (← links)
- Infliximab in the treatment of plaque type psoriasis (Q34620291) (← links)
- Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis (Q35763195) (← links)
- Effect of interleukin-17 on receptor-interacting protein 4 expression and keratinocyte proliferation (Q35802662) (← links)
- Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis (Q35902459) (← links)
- Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. (Q36761374) (← links)
- Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice (Q37032431) (← links)
- The two-faced NF-kappaB in the skin. (Q37198675) (← links)
- Th17 cells: a new paradigm for cutaneous inflammation (Q37217449) (← links)
- Angiogenesis drives psoriasis pathogenesis (Q37534974) (← links)
- HIV-associated psoriasis: pathogenesis, clinical features, and management (Q37770792) (← links)
- Psoriasis: what we have learned from mouse models (Q37793830) (← links)
- Interleukin-19: Multiple roles in immune regulation and disease (Q37796413) (← links)
- Inverse psoriasis: case presentation and review (Q37823897) (← links)
- Targeting interleukin-21 in inflammatory diseases (Q37851522) (← links)
- New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis (Q38799600) (← links)
- Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity (Q39026209) (← links)
- Immunometabolism of human autoimmune diseases: from metabolites to extracellular vesicles. (Q39397975) (← links)
- NADPH Oxidase-Derived Superoxide Provides a Third Signal for CD4 T Cell Effector Responses (Q39543844) (← links)
- Hydrogen sulfide inhibits IL-8 expression in human keratinocytes via MAP kinase signaling. (Q39545584) (← links)
- Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation. (Q40987197) (← links)
- Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells (Q41860308) (← links)
- Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis (Q41888146) (← links)
- Interleukin-1 receptors are differentially expressed in normal and psoriatic T cells (Q41977448) (← links)
- Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis (Q42568263) (← links)
- Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life (Q43645804) (← links)
- Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis (Q43861409) (← links)
- Immunohistochemical Expression of Caspase-3 in Psoriasis (Q45851112) (← links)
- Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis (Q46170910) (← links)
- Regulatory T cells control VEGF-dependent skin inflammation (Q46226178) (← links)
- Study of serum levels and skin expression of S100B protein in psoriasis (Q46956389) (← links)
- Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis. (Q47687532) (← links)
- Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. (Q48281683) (← links)
- The beneficial effect of total glucosides of paeony on psoriatic arthritis links to circulating Tregs and Th1 cell function (Q51050640) (← links)
- Alefacept treatment for refractory chronic extensive GVHD. (Q51961388) (← links)